Bullous pemphigoid (BP) is an autoimmune blistering disorder occurring mostly in the
elderly. The standard treatment of BP patients with systemic corticosteroid have some …

Bullous pemphigoid (BP) is an autoimmune blistering disorder occurring mostly in the
elderly. The standard treatment of BP patients with systemic corticosteroid have some …

A 64-year-old Taiwanese male, nonsmoker, with a history of hypertension and type 2
diabetes mellitus has been regularly taking metformin for glycemic control. The patient was …

We report a case of aggressive bullous pemphigoid (BP) concurrent with plaque psoriasis
successfully treated with Janus kinase inhibitor Baricitinib. The 83‐year‐old Chinese man …

Bullous pemphigoid (BP) is a chronic autoimmune blistering disorder defined by
autoantibody formation to hemidesmosomal proteins in the basement membrane zone of the …

Discussion BP is a chronic and highly debilitating disease with a paucity of effective
treatments. Treatment goals involve reducing blisters and pruritis, promoting healing, and …

Bullous pemphigoid (BP) is the most common autoimmune blistering disease. First-line
treatment with niacinamide, doxycycline, and topical and/or systemic corticosteroids is often …

DigitalCommons@PCOM - Research Day: Treatment of bullous pemphigoid with dupilumab: A
case report Home Search Browse Collections My Account About DC Network Digital Commons …

Bullous pemphigoid (BP) is a blistering autoimmune skin disease. Omalizumab, a
monoclonal antibody directed to IgE, showed a beneficial effect in treatment of recalcitrant …

Background Bruton tyrosine kinase (BTK) inhibition targets B‐cell and other non‐T‐cell
immune cells implicated in the pathophysiology of pemphigus, an autoimmune disease …